Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy. [electronic resource]
Producer: 20130509Description: 254-63 p. digitalISSN:- 1941-3297
- Age Factors
- Aged
- Aged, 80 and over
- Anemia -- blood
- Biomarkers -- blood
- Chi-Square Distribution
- Comorbidity
- Epoetin Alfa
- Erythropoietin -- therapeutic use
- Exercise Test
- Exercise Tolerance -- drug effects
- Female
- Heart Failure -- blood
- Hematinics -- therapeutic use
- Hemoglobins -- metabolism
- Humans
- Male
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- New York City -- epidemiology
- Prospective Studies
- Quality of Life
- Recombinant Proteins -- therapeutic use
- Recovery of Function
- Single-Blind Method
- Stroke Volume -- drug effects
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
- Ventricular Remodeling -- drug effects
- Walking
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.